By proceeding, you agree to our Terms of Use and Privacy Policy.
Built with biopharmaceutical industry insights, this in-person conference will delve into novel and emerging RNA therapeutics and vaccines such as self-amplifying mRNA vaccines, circular RNA therapeutics and tRNA-based gene therapies for discovery and translation of novel modalities that offer superior targeted delivery, selectivity, durability, an
This event will share the major breakthroughs in the field of RNA therapeutics, opening the gates to investment and collaboration opportunities to address unmet clinical needs.
Get introduced to 20+ pioneering speakers from large pharma, innovative biotech, and KOLs of academia who are shaping the landscape of next generation RNA therapeutics.
Be at the Event! Next generation RNA therapeutics and vaccines offer superior targeted delivery, selectivity, durability and scalability compared to the current generations.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.
Etherna (“the Company”), a leading mRNA technologies company, announced today that Antonin (Tony) de Fougerolles has joined its board of directors as an independent member.
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.